Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Are there studies looking at Ra-223 and SBRT for oligometastatic disease in the setting of mCRPC?
Answer from: Radiation Oncologist at Community Practice
Yes, quite a few including one from UCLA- NCT05496959
Sign in or Register to read more
18046
Related Questions
Is there any evidence that ivermectin suppresses the PSA level in prostate cancer?
What would your approach be in a man currently on treatment for high-risk prostate cancer with ADT who does not have castrate levels of testosterone?
How do you reconcile discordant PSMA and MRI findings in patients undergoing definitive radiotherapy for prostate cancer?
How do you interpret recent large retrospective analyses comparing radical prostatectomy vs. radiation for prostate cancer?
How do you manage LUTS in the post-prostatectomy setting?
How would you manage T3N0M0 sarcomatoid carcinoma of the prostate with Adenosquamous differentiation s/p prostatectomy?
How would you treat a patient with a post prostatectomy biochemical and pelvic nodal recurrence with a BLM mutation?
Can a PSA bounce be seen shortly after SBRT to prostate cancer oligometastases while on androgen deprivation therapy?
Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?
What is your preferred approach in a patient unable to fill their bladder during prostate radiotherapy?